ФУНКЦИЯ ЭНДОТЕЛИЯ ПРИ ПАРОКСИЗМАЛЬНОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
Аннотация
Показано наличие дисфункции эндотелия (ДЭ), установленной по величине эндотелий-зависимой вазодилатации (ЭЗВД), у больных с пароксизмальной фибрилляцией предсердий (ФП) относительно пациентов с кардиоваскулярной патологией без аритмии, а также возможности ее коррекции на основе стратегии контроля ритма с включением различных ингибиторов ангиотензин-превращающего фермента (иАПФ). Установлена независимая ассоциация между величиной вазодилатации и парциальным давлением углекислого газа в крови.
Литература
Зинчук, В.В. Дисфункция эндотелия и кислородсвязывающие свойства гемоглобина/В.В. Зинчук//Кардиология. -2009. -№ 7-8. -С. 81-89.
Пронько, Т.П. Функция эндотелия и кислородтранспортная функция крови у курящих и некурящих больных ИБС/Т.П. Пронько, М.А. Лис, М.А. Добродей//Здоровье и окружающая среда: сб. науч. тр. -Минск, 2006. -С. 649-654.
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE/C. Ceconi [et al.]//Eur. J. Pharmacol. -2007. -Vol. 577, № 1-3. -P. 1-6.
Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation/A. Bukowska [et al.]//Cardiovasc. Pathol. -2010. -Vol. 19, № 3. -P. e51-e60.
Atrial fibrillation impairs endothelial function of forearm vessels in humans/N. Takahashi [et al.]//J. Card. Fail. -2001. -Vol. 7, № 1. -P. 45-54.
Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors/C.I. Johnston [et al.]//J. Hypertens. Suppl. -1989. -Vol. 7, № 5. -P. S11-16.
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies/C. Ceconi [et al.]//Cardiovasc. Drugs Ther. -2007. -Vol. 21, № 6. -P. 423-429.
Downregulation of endocardial nitric oxide sinthase expression and nitric oxide production in atrial fibrillation. Potential mechanisms for atrial thrombosis and stroke/H. Cai [et al.]//Circulation. -2002. -Vol. 106. -P. 2854-2858.
Ehrlich, J.R. Novel approaches for pharmacological management of atrial fibrillation/J.R. Ehrlich, S. Nattel//Drugs. -2009. -Vol. 69, № 7. -P. 757-774.
Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm/E.I. Skalidis [et al.]//Am. J. Cardiol. -2007. -Vol. 99, № 9. -P. 1258-1262.
Gross, S.S. Physiological reactions of nitric oxide and hemoglobin: a radical rethink/S.S. Gross, P. Lans//Proc. Natl. Acad. Sci. USA. -1999. -Vol. 96, № 18. -P. 9967-9969.
Guazzi, M. Endothelial dysfunction and pathophysiological correlates in atrial fibrillation/M. Guazzi, R. Arena//Heart. -2009. -Vol. 95. -P. 102-106.
Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)/A.J. Camm [et al.]//Eur. Heart J. -2010. -Vol. 31. -P. 2369-2429.
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force/M.C. Corretti [et al.]//J. Am. Coll. Cardiol. -2002. -Vol. 39, № 2. -P. 257-265. http://elibrary.ru/pic/tr_red2.gif
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels/B. Freestone [et al.]//Thromb. Res. -2008. -Vol. 122, № 1. -P. 85-90.
Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation/S.Y. Shin [et al.]//J. Cardiovasc. Electrophysiol. [Electronic resource]. 2010. -Mode of access: http://www.ncbi.nlm.nih.gov/pubmed/20958832. -Date of access: 25.12.2010.
Krishnamoorthy, S. Assessment of endothelial (dys)function in atrial fibrillation/S. Krishnamoorthy, S.H. Lim, G.Y. Lip//Ann Med. -2009. -Vol. 41, № 8. -P. 576-590.
Lerman, A. Endothelial Function: Cardiac Events/A. Lerman, A.M. Zeiher//Circulation. -2005. -Vol. 111. -P. 363-368.
Nitric oxide synthesis by cultured endothelial cells is modulated by flow condition/M. Noris [et al.]//Circ. Res. -1995. -Vol. 76. -P. 536-543.
Reference values for arterial blood gases in the elderly/J.A. Hardie [et al.]//Chest. -2004. -Vol. 125, № 6. -P. 2053-2060.
Renin-angiotensin system and cardiovascular risk/R.E. Schmieder [et al.]//Lancet. -2007. -Vol. 369, № 9568. -P. 12081219.
Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation/M.T. Gladwin [et al.]//Adv. Exp. Med. Biol. -2006. -Vol. 588. -P. 189-205.
Stein, P.K. Insights from the study of heart rate variability/P.K. Stein, R.E. Kleiger//Annu. Rev. Med. -1999. -Vol. 50. -P. 249261.
The lipophilic properties of angiotensin I-converting enzyme inhibitors do not influence their diffusion through cultured endothelium/W. Raasch [et al.]//Jpn. J. Pharmacol. -1999. -Vol. 81, № 4. -P. 346-352.
Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent/L. Comini [et al.]//Pharmacol. Res. -2007. -Vol. 56, № 1. -P. 42-48.
